Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Vaccines in Development for Opioid Combinations

Researchers studying the immune system as a weapon against opioid addiction say they can develop vaccines that block combinations of opioids, like those sold on the street. . . . → Read More: Vaccines in Development for Opioid Combinations

AstraZeneca, Biotech Partner on Messenger RNA Therapies

Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments. . . . → Read More: AstraZeneca, Biotech Partner on Messenger RNA Therapies

Trial Testing Engineered Virus as Cancer Treatment

A clinical trial is underway testing a genetically engineered virus to kill cancer cells, then stimulate the immune system to treat solid tumor cancers. . . . → Read More: Trial Testing Engineered Virus as Cancer Treatment

Viruses Removed from Pig Organs for Human Transplants

Researchers in the U.S., Denmark, and China devised a process with genome editing to remove viruses that prevent organs from pigs from being used for human transplants. . . . → Read More: Viruses Removed from Pig Organs for Human Transplants

Gene-Edited Skin Grafts Shown to Control Glucose Levels

Skin grafts derived from genetically edited stem cells were shown in tests with lab mice to reduce glucose levels and weight gain that result from a high-fat diet. . . . → Read More: Gene-Edited Skin Grafts Shown to Control Glucose Levels

Gene Editing, Therapy Company Gains $83.5M in Venture Funds

A biotechnology company designing treatments with gene edits and transfers using benign viruses is raising $83.5 million in its second venture funding round. . . . → Read More: Gene Editing, Therapy Company Gains $83.5M in Venture Funds

Engineered Viruses Studied to Improve Plant Traits.

A research study funded by the U.S. Department of Defense is investigating genetic alterations of plant viruses for delivery of genes to quickly protect corn crops against threats like pests and drought. . . . → Read More: Engineered Viruses Studied to Improve Plant Traits.

RNA Vaccine for Rabies Found Safe, Generates Antibodies

A vaccine to prevent rabies made from messenger RNA, genetic material transcribed from DNA, was shown in a clinical trial to be generally safe and able under some conditions to induce antibodies. . . . → Read More: RNA Vaccine for Rabies Found Safe, Generates Antibodies

Faster Process Devised for Targeted Antibodies

Researchers in the U.S. and U.K. designed techniques for quickly generating highly targeted antibodies in the lab, which can speed production of new vaccines and therapies. . . . → Read More: Faster Process Devised for Targeted Antibodies

Lilly Licensing Autoimmune Therapy in $400M Deal

Drug maker Eli Lilly and Company is licensing a therapy from a biotechnology company that produces self-correcting cells for people with disorders caused by a malfunctioning immune system. . . . → Read More: Lilly Licensing Autoimmune Therapy in $400M Deal